What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
His primary areas of study are Multiple myeloma, Internal medicine, Surgery, Cancer and Bortezomib.
His studies in Multiple myeloma integrate themes in fields like Bone disease and Bone marrow, Pathology.
His studies deal with areas such as Immunology, Endocrinology and Oncology as well as Internal medicine.
When carried out as part of a general Surgery research project, his work on Fever of unknown origin, Neutropenia and Absolute neutrophil count is frequently linked to work in Cefepime, therefore connecting diverse disciplines of study.
His research on Cancer also deals with topics like
- Psychometrics and related Prospective cohort study,
- Physical therapy and related Quality of life.
His Bortezomib research integrates issues from Proteasome inhibitor, Corticosteroid and Chemotherapy.
His most cited work include:
- Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis (947 citations)
- International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. (634 citations)
- Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma (591 citations)
What are the main themes of his work throughout his whole career to date?
Orhan Sezer mostly deals with Multiple myeloma, Internal medicine, Oncology, Cancer research and Surgery.
His Multiple myeloma research incorporates elements of Bone disease and Bone marrow, Pathology.
His work deals with themes such as Gastroenterology and Endocrinology, which intersect with Internal medicine.
His Oncology study integrates concerns from other disciplines, such as Gemcitabine, Hematopoietic stem cell transplantation, Metastatic breast cancer and Autologous stem-cell transplantation.
His Cancer research research is multidisciplinary, incorporating elements of Apoptosis, Osteoclast and Cell growth.
He interconnects Cancer and Quality of life in the investigation of issues within Surgery.
He most often published in these fields:
- Multiple myeloma (44.40%)
- Internal medicine (44.40%)
- Oncology (20.75%)
What were the highlights of his more recent work (between 2007-2021)?
- Multiple myeloma (44.40%)
- Internal medicine (44.40%)
- Oncology (20.75%)
In recent papers he was focusing on the following fields of study:
Orhan Sezer spends much of his time researching Multiple myeloma, Internal medicine, Oncology, Surgery and Bortezomib.
His Multiple myeloma research includes themes of Cancer research, Bone disease and Transplantation.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Endocrinology.
As a part of the same scientific study, Orhan Sezer usually deals with the Oncology, concentrating on Stage and frequently concerns with Multivariate analysis.
His Surgery research incorporates themes from Cancer, Tolerability and Urology.
His study looks at the relationship between Bortezomib and topics such as Proteasome inhibitor, which overlap with Cell cycle.
Between 2007 and 2021, his most popular works were:
- International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. (634 citations)
- Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma (591 citations)
- International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders (554 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
Orhan Sezer mainly focuses on Multiple myeloma, Internal medicine, Surgery, Oncology and Cancer.
The various areas that Orhan Sezer examines in his Multiple myeloma study include Bone disease and Transplantation.
Internal medicine is closely attributed to Immunology in his study.
In his study, Psychometrics and Colorectal cancer is strongly linked to Clinical trial, which falls under the umbrella field of Oncology.
His Cancer research includes elements of Physical therapy and Quality of life.
His Bortezomib research integrates issues from Cancer research and Adverse effect, Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
